The goal of this study is to assess the effects of nicotine concentration and its interplay with pH on sensory experience, product appeal, and abuse liability of NPs among young adults NP users. Primary objective is to assess the effect of variation in nicotine concentration in nicotine pouches (NPs) and its interaction effect with pH level on three proximal outcomes of relevance to regulation: (1) sensory experience, (2) product appeal, and (3) abuse liability of NPs.
Oral nicotine pouches (NPs) are a rapidly growing segment of nicotine products regulated by the U.S. Food and Drug Administration (FDA). These microfiber pouches contain nicotine but no tobacco leaf, and they dissolve in the mouth without requiring spitting. Between late 2019 and early 2022, NP sales surged from 126 million to 808 million units. Their sleek packaging, concealability, and "tobacco-free" claims have made them particularly appealing to young adults, with recent studies showing that over 10% of young adults reported using NPs in the past 30 days. However, this popularity raises health concerns. NPs deliver nicotine efficiently through buccal absorption, leading to rapid increases in blood nicotine levels, which may contribute to oral toxicity, cardiovascular effects, and nicotine dependence. These factors also elevate the abuse liability of NPs-defined as the likelihood of non-medical use leading to harmful consequences. The FDA has the authority to impose stricter regulations on products with characteristics that enhance appeal and sensory experience, especially among youth. For instance, the agency has proposed banning menthol cigarettes due to their ability to mask irritation and encourage deeper inhalation of nicotine. Similar regulatory scrutiny is now being applied to emerging products like NPs. One key factor influencing product appeal is nicotine formulation. Free-base nicotine, commonly used in non-combustible products like e-cigarettes (ECs), has aversive effects such as bitterness and airway irritation, especially at high concentrations. To counter this, manufacturers began adding organic acids to convert nicotine into a protonated salt, lowering the product's pH and improving its palatability. This shift not only enhances the sensory experience but also increases the abuse liability of high-nicotine products. Evidence suggests that regulating acid additives or setting minimum pH levels could reduce the appeal of these products. Since NPs also use acid additives to lower pH, they share similar characteristics with ECs that attract young users, underscoring the need for targeted regulatory action.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
BASIC_SCIENCE
Masking
NONE
Enrollment
84
Rollins School of Public Health
Atlanta, Georgia, United States
Abuse liability: Amount of time with Nicotine product
Total amount of time with Nicotine Pouches in mouth (excluding periods in between NPs after disposal)
Time frame: Visit 1, Visit 2, Visit 3, Visit 4 (all visits within 2-4 weeks)
Abuse liability: Number of Nicotine Pouches used
Total number of Nicotine Pouches used (i.e., larger number and longer time with Nicotine Pouches, higher abuse ability.
Time frame: Visit 1, Visit 2, Visit 3, Visit 4 (all visits within 2-4 weeks)
Subjective effects measures: Drug Effects Questionnaire
During the session, participants will also repeatedly (every 30 min) complete the subjective effects measures of abuse liability of NP (using VAS), which will be developed based on the Drug Effects Questionnaire (DEQ). A modified version of the DEQ will be used to rate acute responses to the NP on the Visual Analogue Scale (range, 0-100). Items assess liking/wanting (e.g., "I enjoy nicotine buzz," "I feel good effects from the NP," "I want more," "I feel the NP strength," and "I like the NP effect").
Time frame: Visit 1, Visit 2, Visit 3, Visit 4 (all visits within 2-4 weeks)
Subjective effects measures: Modified Cigarette Evaluation Questionnaire
Modified Cigarette Evaluation Questionnaire will also be used to measure domains of subjective reinforcing effects (product satisfaction, psychological reward; e.g., "NP is satisfying" on a 7-point scale (0-7).
Time frame: Visit 1, Visit 2, Visit 3, Visit 4 (all visits within 2-4 weeks)
Product appeal
After each administration, participants will use visual analogue scales (VAS, 0-100 range) to rate the product they just used: (1) "How much did you like the product?" (liking); (2) "How much did you dislike the product?" (disliking); and (3) "Would you use the product again?" (use again). A composite appeal score will also be calculated by averaging the 3 appeal ratings (Cronbach's α will be estimated to assess scale reliability; disliking will be reverse-scored).
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Nicotine pouch with high pH level \[\>8.5\]
Time frame: Visit 1, Visit 2, Visit 3, Visit 4 (all visits within 2-4 weeks)
Sensory Attribute
Participants will answer following sensory quality questions: (1) "How sweet was the product?"; (2) smooth?; (3) bitter?; and (4) harsh? (VAS 0-100, "Not at all" to "Extremely". Burning and tingling sensation will be measured at each trial.
Time frame: Visit 1, Visit 2, Visit 3, Visit 4 (all visits within 2-4 weeks)
Nicotine product use history: Number of days
Information will be collected on past 30-day number of days used nicotine pouches (NPs)
Time frame: past 30-day
Nicotine product use history: Number of Nicotine product
Number of Nicotine product used per day
Time frame: past 30-day
Nicotine product use history: Amount of time with Nicotine product
Amount of time with Nicotine product in mouth per episode
Time frame: past 30-day
Nicotine Pouches brand
Data on brand names of NPs will be collected
Time frame: past 30-day
Number of e- cigarettes
Number of e- cigarettes used in past 30 days.
Time frame: past 30-day
Tobacco use
Number of tobacco products used in last 30 days
Time frame: past 30-day